Unit 5
Naomi Sun
a day ago
10
files (1)NU553_Unit_5_Template.docx
NU553_Unit_5_Template.docx
NU553 Unit 5 Template
Review the grading rubric.
Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders
Student Name:
Date:
Instructor Name:
Introduction
Communication Techniques
Patients and Families.
Interprofessional Teams.
Shared Decision Making
Patients and Families.
Interprofessional Teams.
Nonprescriptive Considerations
Determinants of Health Considerations
|
Anticoagulant Agents |
|||||||
|
Drug Class
Drug Name Brand/ Generic |
Indications and Uses |
Mechanism of Action |
Dosage and Considerations
|
Interactions |
Contraindications |
Antedote
|
Monitoring Goals/ Labs
|
|
UFH
|
|
|
|
|
|
|
|
|
LMWH |
|
|
|
|
|
|
|
|
VKA |
|
|
|
|
|
|
|
|
DOAC (DTI) |
|
|
|
|
|
|
|
|
DOAC (Xa Inhibitor) |
|
|
|
|
|
|
|
|
APT |
|
|
|
|
|
|
|
|
tPA Thrombolytic |
|
|
|
|
|
|
|
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
